- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/655 - Somatostatins
Patent holdings for IPC class C07K 14/655
Total number of patents in this class: 143
10-year publication summary
|
14
|
9
|
8
|
12
|
7
|
3
|
10
|
2
|
2
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glytech, Inc. | 65 |
8 |
| BCN Peptides, S.A. | 32 |
6 |
| Braasch Biotech LLC | 8 |
5 |
| Immunwork Inc. | 25 |
5 |
| Tel Hashomer Medical Research Infrastructure and Services Ltd. | 330 |
5 |
| Ipsen Pharma S.A.S. | 375 |
4 |
| The Salk Institute for Biological Studies | 445 |
4 |
| Adepthera LLC | 12 |
4 |
| UCL Business Ltd | 597 |
4 |
| Novartis AG | 10847 |
3 |
| The Administrators of the Tulane Educational Fund | 391 |
3 |
| Camurus AB | 143 |
3 |
| Ipsen Manufacturing Ireland Limited | 7 |
3 |
| Italfarmaco SpA | 147 |
3 |
| University Hospital Basel | 14 |
3 |
| Recordati AG | 41 |
3 |
| Taurus Biosciences, LLC | 8 |
3 |
| The Regents of the University of California | 19898 |
2 |
| Alchemia Limited | 3 |
2 |
| AmideBio, LLC | 15 |
2 |
| Other owners | 68 |